Ananth J, Engelsmann F, Kiriakos R, Kolivakis T
Acta Psychiatr Scand. 1979 Sep;60(3):279-86. doi: 10.1111/j.1600-0447.1979.tb00276.x.
Even though lithium has been established as an effective agent in the management of primary affective disorders, not all manic-depressive patients respond favourably to lithium therapy. Therefore we attempted to delineate lithium responders from non-responders in a group of 54 manic-depressive patients on the basis of an assessment which included 64 variables and the results showed that only two thirds were pure responders. Females, patients with prior manic episodes, onset of the illness initially with a manic episode, and premorbid psychothymic personality were all indicators of favourable long-term lithium response. Patients with retarded depression, severe anxiety, though disorder and those with higher scores on the Psychopathic Deviate and Paranoia scales of the MMPI were poor lithium responders. It should be noted, however, that only a few of the differences between responders and non-responders were statistically significant. Our study suggests a number of predictive variables for the identification of lithium responders.
尽管锂盐已被确认为治疗原发性情感障碍的有效药物,但并非所有躁郁症患者对锂盐治疗都有良好反应。因此,我们试图在一组54名躁郁症患者中,根据包含64个变量的评估来区分锂盐反应者和无反应者,结果显示只有三分之二是单纯的反应者。女性、有过躁狂发作史的患者、疾病最初以躁狂发作为起病形式以及病前有环性人格的患者,都是锂盐长期反应良好的指标。伴有迟滞性抑郁、严重焦虑、精神分裂症的患者以及在明尼苏达多相人格调查表(MMPI)的精神病态偏差和偏执量表上得分较高的患者,对锂盐反应较差。然而,应该注意的是,反应者和无反应者之间只有少数差异具有统计学意义。我们的研究提出了一些用于识别锂盐反应者的预测变量。